Ashwath Jayagopal insider trades: Opus Genetics (IRD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ashwath reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | IRD | ↓ Sell | 3,719 | $5.12 | $19K | Direct | Mar 18, 2026 (2d) |
| May 22, 2024 | OCUP | ↑ Buy | 3,500 | $1.76 | $6K | Direct | May 24, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRD insiders
Open-market trades in the last 12 months
About Ashwath Jayagopal's insider trades
Ashwath Jayagopal is Chief Scientific & Dev. Ofc. at Opus Genetics (IRD). Since May 22, 2024, Ashwath has reported 1 open-market purchase worth $6K and 1 sale worth $19K on SEC Form 4. In the last 12 months: 1 sale ($19K).
Their filings also include grants and awards (3 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.